|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 606, Lariboisière Hospital, and University of Paris, Paris, France (G.M.S., V.A., A.L.); Medical Research Council, Laboratory of Molecular Biology, Cambridge, United Kingdom (G.M.S.); Molecular Pharmacology Laboratory, Department of Pharmaceutical Sciences, School of Health Sciences, University of Brasilia, Brasilia, Brazil (G.B.B., M.T., F.A.R.N.); Diabetes Center and Department of Medicine, University of California School of Medicine, San Francisco, California (M.T., P.W.); and University of Cergy-Pontoise, Unité de Formation et de Recherche des Sciences et Techniques, GRP2H-INSERM Unité 680, Département de Biologie, Cergy-Pontoise, France (G.M.S., N.L.)
The role of thyroid hormone [L-3,5,3'-triiodothyronine (T3)] and the thyroid hormone receptor (TR) in regulating growth, development, and metabolic homeostasis is well established. It is also emerging that T3 is associated with oxidative stress through the regulation of the activity of superoxide dismutase-1 (SOD-1), a key enzyme in the metabolism of oxygen free radicals. We found that T3 reverses the activation of the SOD-1 promoter caused by the free radical generators paraquat and phorbol 12-myristate 13-acetate through the direct repression of the SOD-1 promoter by liganded TR. Conversely, the SOD-1 promoter is significantly stimulated by unliganded TRs. This regulation requires the DNA-binding domain of the TR, which is recruited to an inhibitory element between -157 and +17 of the SOD-1 promoter. TR mutations, which abolish recruitment of coactivator proteins, block repression of the SOD-1 promoter. Conversely, a mutation that inhibits corepressor binding to the TR prevents activation. Together, our findings suggest a mechanism of negative regulation in which TR binds to the SOD-1 promoter but coactivator and corepressor binding surfaces have an inverted function. This effect may be important in T3 induction of oxidative stress in thyroid hormone excess.
Address correspondence to: Abderrahim Lomri, INSERM Unité 606, Lariboisiere Hospital, 2, rue Ambroise Paré, 75475 Paris Cedex 10, France. E-mail: lomri{at}larib.inserm.fr
This article has been cited by other articles:
![]() |
A. Wulf, M. G Wetzel, M. Kebenko, M. Kroger, A. Harneit, J. Merz, and J. M Weitzel The role of thyroid hormone receptor DNA binding in negative thyroid hormone-mediated gene transcription J. Mol. Endocrinol., July 1, 2008; 41(1): 25 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Gravina, C. K. B. da Silveira, A. M. de Assis, D. K. Rieger, C. Guerini, A. P. Muller, M. Farina, L. N. Rotta, and M. L. S. Perry Experimental Hypothyroidism Inhibits {delta}-Aminolevulinate Dehydratase Activity in Neonatal Rat Blood and Liver Experimental Biology and Medicine, September 1, 2007; 232(8): 1021 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. R. Velasco, M. Togashi, P. G. Walfish, R. P. Pessanha, F. N. Moura, G. B. Barra, P. Nguyen, R. Rebong, C. Yuan, L. A. Simeoni, et al. Thyroid Hormone Response Element Organization Dictates the Composition of Active Receptor J. Biol. Chem., April 27, 2007; 282(17): 12458 - 12466. [Abstract] [Full Text] [PDF] |
||||